The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PATRIOT II: An ambispective, observational, multicenter, 2-cohort study of avelumab (Ave) first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) in the United States.
 
Petros Grivas
Consulting or Advisory Role - 4D Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dyania Health; EMD Serono; Exelixis; Genentech; GlaxoSmithKline; Guardant Health; Immunomedics; Infinity Pharmaceuticals; Janssen; Merck; Mirati Therapeutics; Pfizer; QED Therapeutics; Regeneron; Roche; Seagen
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Kure It Cancer Research (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst)
 
Pedro C. Barata
Consulting or Advisory Role - Bayer; BMS; Caris Life Sciences; Clovis Oncology (Inst); Dendreon (Inst); Eisai; EMD Serono; Pfizer
Research Funding - Blue Earth Diagnostics (Inst)
 
Helen Moon
Consulting or Advisory Role - Bayer; EMD Serono; Pfizer; Seagen
Research Funding - Apollomics; Bristol-Myers Squibb; EMD Serono; Janssen; Nektar; Seagen
 
Thomas E. Hutson
Employment - Texas Oncology
Honoraria - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Johnson & Johnson (Inst); Pfizer (Inst)
 
Shilpa Gupta
Stock and Other Ownership Interests - Moderna Therapeutics; Nektar
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AVEO; EMD Serono; Gilead Sciences; Guardant Health; Loxo/Lilly; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology
 
Cora N. Sternberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Foundation Medicine; Genzyme; Immunomedics; Incyte; Medscape; Merck; MSD; Pfizer; Roche; UroToday
 
A. Simon Pickard
Stock and Other Ownership Interests - Second City Outcomes Research
Patents, Royalties, Other Intellectual Property - University of Illinois- Chicago
 
Vaidehi Dave
No Relationships to Disclose
 
Natalia Han
No Relationships to Disclose
 
Alicia C. Shillington
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; EPI-Q; Johnson & Johnson
Research Funding - Acceleron Pharma; Amolyt Pharma; Bristol-Myers Squibb; ChemoCentryx; EMD Serono; Janssen; Merck KGaA; Neurocrine Biosciences; Pfizer; scPharmaceuticals; United Therapeutics
 
Geeta Devgan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Ruth Kim
Employment - Pfizer
Stock and Other Ownership Interests - Bristol-Myers Squibb; Exelixis
Research Funding - Pfizer
 
Sheena Thakkar
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Howard Katzenstein
Employment - EMD Serono
 
Abhijeet Bhanegaonkar
Employment - EMD Serono
Stock and Other Ownership Interests - EMD Serono
Travel, Accommodations, Expenses - EMD Serono
 
Frank Liu
Employment - EMD Serono
Stock and Other Ownership Interests - EMD Serono
 
Guru P. Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; G1 Therapeutics; Genentech; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Loxo/Lilly; Merck; Pfizer; Scholar Rock; Seagen
Speakers' Bureau - Medscape; Onclive; Physicans' Education Resource; Research to Practice
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Janssen (Inst); Predicine (Inst); QED Therapeutics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Astellas Pharma; AstraZeneca; Bavarian Nordic; Bristol-Myers Squibb; Debiopharm Group; Elsevier; G1 Therapeutics; Mereo BioPharma; QED Therapeutics